Clinical trial registry record

Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated March 8, 2024.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT03508765
Last registry update
March 8, 2024
Status
Completed
Phase
Phase not reported
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
18
Countries
United States
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
NA · SINGLE GROUP · DIAGNOSTIC · NONE
Evidence population
Human clinical study registration
Participants
18
Population
ALL · 60 Years to 75 Years
Duration
2018-03-27 to 2024-03-06
Intervention
Structural Image; Functional Image; Digit Span subtest; Brief Test of Attention; Trail Making Test (Parts A & B); Auditory Consonant Trigrams Test; Controlled Oral Word Association Test; Hopkins Verbal Learning Test-Revised; The Center for Epidemiological Study-Depression; The Functional Assessment of Chronic Illness Therapy-Fatigue Subscale, Version 4; Blood draw
Comparator
Not reported
Outcomes measured
Changes in neurocognitive functions in older participants with Multiple Myeloma following high-dose (HD) chemotherapy a…; Changes in regional brain volume and functional connectivity when baseline and follow-up MRIs are compared. — up to 4 m…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 80% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Stem cells · 80%Title contains controlled topic terminology. Title supplies ageing or longevity context.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

stem cells
Read the original source →Export JSON